Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stan N Finkelstein

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
American Journal of Disaster Medicine|April 7, 2011
Vaccine availability in the United States during the 2009 H1N1 outbreakStan N Finkelstein, Kallie J Hedberg, Julia A Hopkins, et al.
Biotechnology Journal|May 26, 2019
Bringing Stem Cell-Based Therapies for Type 1 Diabetes to the Clinic: Early Insights from Bioprocess Economics and Cost-Effectiveness AnalysisCátia Bandeiras, Joaquim M S Cabral, Robert A Gabbay, et al.
The American Journal of Managed Care|June 24, 2004
Costs of antidepressant medications associated with inadequate treatmentJeffrey B Weilburg, Randall S Stafford, Kathleen M O'Leary, et al.
Journal of Public Health (Oxford, England)|February 4, 2017
Preventive behaviors and perceptions of influenza vaccination among a university student populationSahar Hashmi, Lisa D'Ambrosio, David V Diamond, et al.
JAMA|January 8, 2004
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002Randall S Stafford, Curt D Furberg, Stan N Finkelstein, et al.
Current Diabetes Reports|August 4, 2019
Economics of Beta-Cell Replacement TherapyCátia Bandeiras, Albert J Hwa, Joaquim M S Cabral, et al.
Artificial Intelligence in Medicine|February 23, 2013
Missing data in medical databases: impute, delete or classify?Federico Cismondi, André S Fialho, Susana M Vieira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Trends in the use and role of biomarkers in phase I oncology trialsBernardo H L Goulart, Jeffrey W Clark, Homer H Pien, et al.
Frontiers in Health Policy Research|December 23, 2004
Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?William H Crown, Ernst R Berndt, Onur Baser, et al.
Clinical Therapeutics|October 13, 2004
The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plansRonald J Ozminkowski, William D Marder, Kevin Hawkins, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
American Journal of Disaster Medicine|April 7, 2011
Vaccine availability in the United States during the 2009 H1N1 outbreakStan N Finkelstein, Kallie J Hedberg, Julia A Hopkins, et al.
Biotechnology Journal|May 26, 2019
Bringing Stem Cell-Based Therapies for Type 1 Diabetes to the Clinic: Early Insights from Bioprocess Economics and Cost-Effectiveness AnalysisCátia Bandeiras, Joaquim M S Cabral, Robert A Gabbay, et al.
The American Journal of Managed Care|June 24, 2004
Costs of antidepressant medications associated with inadequate treatmentJeffrey B Weilburg, Randall S Stafford, Kathleen M O'Leary, et al.
Journal of Public Health (Oxford, England)|February 4, 2017
Preventive behaviors and perceptions of influenza vaccination among a university student populationSahar Hashmi, Lisa D'Ambrosio, David V Diamond, et al.
JAMA|January 8, 2004
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002Randall S Stafford, Curt D Furberg, Stan N Finkelstein, et al.
Current Diabetes Reports|August 4, 2019
Economics of Beta-Cell Replacement TherapyCátia Bandeiras, Albert J Hwa, Joaquim M S Cabral, et al.
Artificial Intelligence in Medicine|February 23, 2013
Missing data in medical databases: impute, delete or classify?Federico Cismondi, André S Fialho, Susana M Vieira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Trends in the use and role of biomarkers in phase I oncology trialsBernardo H L Goulart, Jeffrey W Clark, Homer H Pien, et al.
Frontiers in Health Policy Research|December 23, 2004
Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?William H Crown, Ernst R Berndt, Onur Baser, et al.
Clinical Therapeutics|October 13, 2004
The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plansRonald J Ozminkowski, William D Marder, Kevin Hawkins, et al.
Pageof 3